The National Comprehensive Cancer Network (NCCN) has treatment recommendations (pdf) and general information for testicular cancer. My pathology report lists the AJCC tumor staging as pt2. Since my CT, X-Rays and blood markers were all negative, I believe translates to Stage IB. This staging is one of the primary determinants of followup treatment.
There are generally three treatment options for Semiomas at this stage.
- Watchful Waiting
- Radiation
- Chemotherapy
Watchful waiting is monitoring through blood markers, chest x-rays and CT scans for up to 10 years. The NCCN recommendations are:
| Years | Blood Work | CT Scans | X-Rays |
|---|---|---|---|
| 1-3 | 4 times | Abdomen/Pelvic 4 times | Chest: twice |
| 4-7 | Twice | Abdomen/Pelvic: twice | Chest: Once |
| After | Once/Year | Abdomen/Pelvic: Once/Year | Chest: every other year |
Watchful waiting works well for early stage seminomas: the side affects of chemotherapy and radiation are avoided, but the recurrence rate is between 15 and 30%. The NCCN guidelines state a 15-20% recurrence rate with the median time to relapse being 12 months, but with relapses reported after 5 years. Keeping up with the monitoring schedule can be tough and if there is a recurrence, the treatment tends to be more invasive as you are now dealing with a metastasized tumor.
Radiation
The second main treatment, and until recently, the standard treatment is 25-30 Gy (2500-3000 rads) of infradiaphragmatic radiation administered to the para-aortic and ipsilateral iliac lymph nodes, the likely first metastization sites. Radiation is very effective in treating Seminoma, but there are potential side affects including: potential infertility and an increased chance of developing cancer later in life.
Chemotherapy
Chemotherapy for seminoma is a relatively new treatment. A study of 1477 people with stage 1 seminoma randomly treated some people with radiation therapy and others with a single course of carboplatin. (second reference) After 5 years, with 1148 patients reporting follow-up results, the relapse-free rates were 94.7% with carboplatin and 96% with radiation. The study authors concluded that a single dose of carboplatin is less toxic and as effective in preventing disease recurrence as radiation therapy in stage 1 seminomas after surgery. There are quite a few side-affects with carboplain, including:
- Decreased white blood counts. Red blood cell counts and platelet counts can also be reduced.
- Nausea, vomiting, and loss of appetite.
- Diarrhea or constipation.
- Numbness and tingling in the hands or feet (peripheral neuropathy).
- Hearing changes or hearing loss.
- Mild rash.
- Hair loss (reversible)
- Mouth sores.
- Changes in kidney and liver function tests
This post took me a couple of hours to write, but it was well worth it. I really had to explore my treatment options in depth and understand a lot of medical and technical terms.
ReplyDeleteI also learned I have a very hard time spelling therapy, I tend to insert an h: theraphy.